5 Interesting Startup Deals You May Have Missed: Blood-Drawing Robots, Inboxes For AI Agents, Franchised Defense Manufacturing, And More

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• 95% of component manufacturing production is done by small businesses

  60% confidence

• Component manufacturing is a $1.8 trillion a year industry

  60% confidence

• AI agents are already starting to function as virtual employees across industries and need their own identity, with email being the heart of identity on the internet

  60% confidence

• The typical owner of small machine shops is more than 65 years old and 40% plan to retire within five years

  60% confidence

• This technology has the potential to establish a new standard of care, much as robotic surgery did in its early days

  60% confidence

• The next billion users of the internet will be AI agents

  60% confidence

• Vitestro is redefining one of the largest and most under innovated clinical workflows with a first-of-its-kind autonomous robotic platform for diagnostic blood collection addressing an enormous unmet global market need

  60% confidence

• Isembard is redefining the process of owning and running a factory by embedding deep operational expertise into an agentic OS

  60% confidence

• Operators are the final line of defense for public health and the environment, and as experience retires out of the industry, tools are needed to support operators in critical decision moments

  60% confidence

Cited in these Via News reports

• Data Processing Units Offload Security Tasks as Global AI Infrastructure Race Intensifies →
• Frontier AI Labs Raise $140B Combined at Valuations Up to $840B While Specialized Startups Follow Traditional Venture Path →
• Global Healthcare VCs Deploy $2B+ Across Clinical Assets While AI Mega-Rounds Concentrate in US Market →
• Global Venture Capital Mints 68 Unicorns in Q1 2026, Already 36% of Last Year's Total →
• OpenAI raises $110B at $840B valuation as global AI funding spreads beyond US foundation models →